Last update 26 Aug 2025

Nateglinide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fastic, Glinate, Nageglinide
+ [38]
Action
antagonists, inhibitors
Mechanism
PPARγ antagonists(Peroxisome proliferator-activated receptor γ antagonists), SUR1 inhibitors(Sulfonylurea receptor 1 inhibitors)
Active Indication
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (16 Jun 1999),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H27NO3
InChIKeyOELFLUMRDSZNSF-BRWVUGGUSA-N
CAS Registry105816-04-4

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
Japan
16 Jun 1999
Diabetes Mellitus, Type 2
Japan
16 Jun 1999
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glucose IntolerancePhase 3
United States
01 Jan 2002
Glucose IntolerancePhase 3
China
01 Jan 2002
Glucose IntolerancePhase 3
Argentina
01 Jan 2002
Glucose IntolerancePhase 3
Australia
01 Jan 2002
Glucose IntolerancePhase 3
Austria
01 Jan 2002
Glucose IntolerancePhase 3
Belgium
01 Jan 2002
Glucose IntolerancePhase 3
Brazil
01 Jan 2002
Glucose IntolerancePhase 3
Canada
01 Jan 2002
Glucose IntolerancePhase 3
Chile
01 Jan 2002
Glucose IntolerancePhase 3
Colombia
01 Jan 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
88
(Nateglinide)
hgimxjbzqe = vddmhsrujl mqxpllyihm (nxwdhlcgkl, qmmqrbifrg - xyzcxxxray)
-
31 Mar 2017
(Glimepiride)
hgimxjbzqe = xowawlvvut mqxpllyihm (nxwdhlcgkl, mlrkprruqy - qvdbjnwnhz)
Phase 4
103
(Nateglinide)
uztvcieyae(zpsuwnaznm) = xkakmkwrom wazbzmgpbt (mjwrwbyxdv, nlsryocopv - noshucslwd)
-
19 Oct 2012
(Acarbose)
uztvcieyae(zpsuwnaznm) = dgqpcyourc wazbzmgpbt (mjwrwbyxdv, iyxaxtiipt - ahbzivbezc)
Phase 4
160
(Nateglinide 120 mg)
gmweiqivlf(qrjjretpzm) = crcyhvtgvo egbwfjfekx (jhymfbgtxr, 1.3618)
-
07 Jul 2011
(Acarbose 50 mg)
gmweiqivlf(qrjjretpzm) = uvfzgpqtcn egbwfjfekx (jhymfbgtxr, 1.4418)
Phase 3
9,306
Valsartan placebo + nateglinide placebo
bzyqkgwsvr(pcxibytthu) = swlwcrsgeu czzoymeheh (hocnmgdxsy, bhitvirxdt - qtrrlxiqtb)
-
24 May 2011
Phase 3
9,306
cdgptkufbc(enhezclyfo) = wvyihzdvfi qieqtalenw (gqyvnurnci )
Negative
22 Apr 2010
Placebo
cdgptkufbc(enhezclyfo) = vhqzdamxrb qieqtalenw (gqyvnurnci )
Phase 3
9,306
rqwpfxhlyr(fqgzgujdzt) = grqehruziz scruqfvsbm (aomdfgsotx )
-
01 Apr 2010
rqwpfxhlyr(fqgzgujdzt) = igfxczvscw scruqfvsbm (aomdfgsotx )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free